Profilaxis preexposición al VIH en España: situación política y administrativa

García, Luis Miguel; Iniesta, Carlos; Garrido, Jorge; Fuster, María José; Pujol, Ferran; Meulbroek, Michael; Poveda, Toni; Riera, Melchor; Antela, Antonio; Moreno, Santiago; Dalmau, David; Rivero, Antonio; García, Diego; Espacio, Ramón; Amo, Julia del.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 37(10): 656-660, dic. 2019. tab
Artículo en Español | IBECS (España) | ID: ibc-189593

Documentos relacionados

  1. A maintenance 3-day-per-week schedule with the single tablet regimen efavirenz/emtricitabine/tenofovir disoproxil fumarate is effective and decreases sub-clinical toxicity.
  2. Anti-HIV Drugs Cause Mitochondrial Dysfunction in Monocyte-Derived Macrophages.
  3. Improved pregnancy outcomes with increasing antiretroviral coverage in South Africa.
  4. Association of HIV Preexposure Prophylaxis Use With HIV Incidence Among Men Who Have Sex With Men in China: A Nonrandomized Controlled Trial.
  5. Prevalence and Associated Factors of Neurocognitive Impairment in HIV-Positive Patients on Effective Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate Treatment.
  6. Coadministration of ARV (Atripla) and Topiramate disrupts quail cardiac neural crest cell migration.
  7. Number of daily pills, dosing schedule, self-reported adherence and health status in 2010: a large cross-sectional study of HIV-infected patients on antiretroviral therapy.
  8. Expansion of HIV Preexposure Prophylaxis to 35 PEPFAR-Supported Early Program Adopters, October 2016-September 2018.
  9. Human Immunodeficiency Virus Type 1 Vpu Inhibitor, BIT225, in Combination with 3-Drug Antiretroviral Therapy: Inflammation and Immune Cell Modulation.
  10. [Efficacy and tolerability of antiretroviral therapy containing tenofovir disoproxil fumarate-emtricitabine-efavirenz in treatment-naive patients infected with HIV-1 in Bobo Dioulasso (Burkina Faso, 2009-2011)].